Kittisak Meepoon Fact checked by:Thailand Medical News Team Nov 30, 2025 57 minutes ago
Medical News: A major new study from Romania is offering fresh hope to people living with chronic hepatitis C, showing that modern antiviral medicines can help the liver heal itself after years of viral damage. The research was carried out by teams from Dunărea de Jos University of Galati, Clinical Emergency County Hospital Sf Ap Andrei, Clinical Children Emergency Hospital Sf Ioan, Clinical Hospital of Infectious Diseases Sf Cuv Parascheva, General Hospital CF Galati, Ovidius University of Constanta, the Clinical Hospital of Infectious Diseases Constanta, and the National Institute of Public Health Bucharest. According to this
Medical News report, more than half of the patients treated in recent years not only cleared the virus but also showed clear signs of liver repair.
Researchers report that new antiviral drug combinations help reverse liver scarring in hepatitis C patients
The Antivirals Used in the Study
All patients received modern direct-acting antivirals, including the combinations ombitasvir/paritaprevir/ritonavir with dasabuvir, ledipasvir/sofosbuvir, elbasvir/grazoprevir, sofosbuvir/velpatasvir, or glecaprevir/pibrentasvir. These treatments are considered breakthrough therapies because they directly block the virus’s ability to reproduce, offering cure rates above 95 percent with minimal side effects.
How the Study Was Conducted
Researchers followed 267 adults who had been infected with the hepatitis C virus and later treated with the antiviral drugs mentioned above. Patients were monitored for up to eight years, with regular evaluations of their liver enzyme levels, fibrosis scores, blood counts, and overall liver function. Fibrosis, or scarring of the liver, is one of the most important indicators used to measure long-term liver damage.
Significant Healing of Liver Damage
Out of the 267 patients, 181 showed improvement in liver fibrosis after completing antiviral therapy. Many moved from moderate or severe fibrosis to much milder stages, and some even improved by two or three fibrosis grades. This demonstrates that once the virus is removed, the liver has a remarkable capacity to regenerate.
Markers of liver inflammation such as ALT and AST dropped sharply within the first month of treatment and remained normal even five years later. Only blood sugar levels did not normalize fully, suggesting that metabolic factors such as diabetes may influence long-term liver healing.
Why Some Patients Did Not Improve
One-third of the patients had stable fibrosis, while a smaller group experienced worsening. Those with the poorest outcomes often had advanced fibrosis before treatment, obesity, diabetes, or continued alcohol intake—all factors known to strain the liver. The researchers emphasize that while antivirals remove the virus, lifestyle and metabolic health still play powerful roles in determining long-term outcomes.
What These Findings Mean
The study shows that mo
dern hepatitis C medications do far more than eliminate the virus—they can spark genuine healing in the liver. The data strongly support early screening, quick initiation of therapy, and ongoing follow-up for anyone treated for hepatitis C. The improvements seen even years after treatment suggest that these antiviral drugs may help reduce future risks of cirrhosis, liver cancer, and severe liver complications.
Conclusions
This research proves that direct-acting antivirals offer long-lasting benefits beyond viral cure. More than half of treated patients showed measurable reversal of liver scarring, while liver function markers stabilized or normalized for years. Although metabolic problems such as diabetes may slow recovery, the overall message is clear: early treatment, careful monitoring, and healthy lifestyle choices can dramatically improve long-term liver health. These findings reinforce the importance of nationwide hepatitis C screening and treatment programs to prevent severe liver disease in the future.
The study findings were published in the peer reviewed Journal of Clinical Medicine.
https://www.mdpi.com/2077-0383/14/22/8112
For the latest on Hepatitis, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/global-hepatitis-deaths-surge-while-most-infected-still-undiagnosed-and-untreated
https://www.thailandmedical.news/news/new-study-explores-the-role-of-timm29-in-the-hepatitis-b-virus-life-cycle
https://www.thailandmedical.news/news/hepatitis-d-virus-study-finds-key-genetic-patterns-and-recombination-risks
https://www.thailandmedical.news/news/repurposed-antiretrovirals-show-potential-for-hepatitis-b-treatment
Share
Tweet
Share
